Radical Catheter’s Neurovascular Device Gets FDA Clearance
Radical Catheter Technologies, backed by NeuroTechnology Investors, received FDA 510(k) clearance for its 8F catheter, expanding its neurovascular product...
Jon Napitupulu
ATTRalus’ Pan-Amyloid Diagnostic Enters Phase 3 Trial
Brigham and Women’s Hospital has initiated enrollment for the Phase 3 REVEAL study of 124I-evuzamitide (AT-01), a diagnostic imaging...
Glaukos iDose Shows Positive Clinical Results
Glaukos Corporation announced positive clinical updates for its iDose® sustained-release drug delivery platform for glaucoma and ocular hypertension. The...
Omada Health Weight Maintenance After GLP-1: New Analysis Shows Successful Results
Omada Health’s analysis reveals that participants in their GLP-1 Enhanced Care Track maintained weight loss 16 weeks after discontinuing...
Umoja Biopharma Gets $100M Series C for In Vivo CAR T-cell Pipeline
Umoja Biopharma, a clinical-stage company developing •in vivo• cell therapies, secured $100 million in Series C funding. The round...
Bayer’s Pharma Growth Strategy Advances Pipeline
Bayer AG announced progress in its pharmaceutical growth strategy at the 43rd J.P. Morgan Healthcare Conference, highlighting regulatory submissions...
Context Therapeutics CTIM-76 Dosed in First Patient of Phase 1 Trial
Context Therapeutics has dosed the first patient in a Phase 1 clinical trial for CTIM-76, a T cell engager...
Eterna Therapeutics ERNA-101 Shows Promise in Preclinical Ovarian Cancer Study
Eterna Therapeutics announced positive preclinical results for its lead cell therapy product, ERNA-101, in treating ovarian cancer. The study...
Positive Clinical Data from Netherton Syndrome Study
Quoin Pharmaceuticals (QNRX) announced positive interim data from its ongoing pediatric Netherton Syndrome clinical study of QRX003, a topical...
Pasithea Opens EU Clinical Trial Sites & Completes Cohort 4 Dosing
Pasithea Therapeutics, a clinical-stage biotechnology company, has expanded its Phase 1 clinical trial of PAS-004, a next-generation MEK inhibitor,...